排序方式: 共有64条查询结果,搜索用时 31 毫秒
1.
Michele C. Hindi-Alexander Ph.D. Maria A. Zielezny Ph.D. Naris Montes R.N. M.S. Bonnie Bullough Ph.D. Elliott Middleton Jr. M.D. Dutzu H. Rosner M.D. William M. London Ed.M. 《The Journal of allergy and clinical immunology》1985,75(6):709-715
After literature reports linking fibrocystic breast disease (FBD) to methylxanthine ingestion, a pilot study was undertaken to investigate the possible contribution of theophylline to this effect. The major goal of this project was to measure the effect of theophylline therapy on FBD in asthmatic women. All women attending an allergy clinic or an obstetrics/gynecology clinic over a 9-month period were examined to clinically assess FBD and were asked to complete a detailed questionnaire covering health history, other risk factors, and drug and dietary methylxanthines. The sample included 62 asthmatic women, 66 allergic but not asthmatic women, and 72 nonallergic and nonasthmatic women. By use of the FBD clinical taxonomy with its 19-point scale going from 0 to 18 that was developed for this study, the three groups did not differ significantly in terms of mean severity of FBD. On analyzing the effect of each of the methylxanthines on FBD severity, there is clear evidence that total methylxanthines was a contributing factor in FBD severity with or without adjustment for relevant variables, such as age, menopause, pregnancies, and groups. Theophylline was significant only when adjustments were made for age, pregnancy, and menopause in contrast to caffeine that was only significant with no adjustments. 相似文献
2.
3.
Quantitative reverse transcription polymerase chain reaction–based detection of thyroid‐specific gene expression in fine‐needle aspirate for thyroid cancer recurrence evaluation: A case report and review of the literature 下载免费PDF全文
Saïd C. Azoury MD Rachel Aufforth MD Mei He MD Zhiming Yang MD PhD Naris Nilubol MD Electron Kebebew MD 《Head & neck》2015,37(11):E165-E168
4.
5.
6.
7.
8.
Allison B. Weisbrod MD MPH Richard C. Webb MD Aarti Mathur MD Stephanie Barak MD Smita Baid Abraham MD Naris Nilubol MD Martha Quezado MD Constantine A. Stratakis MD D.Sc Electron Kebebew MD 《Annals of surgical oncology》2013,20(3):753-758
Background
Primary hyperaldosteronism is most commonly due to a solitary cortical adenoma. Thus, some surgeons have suggested a subtotal adrenalectomy is a reasonable approach when a mass can be identified. On the other hand, adrenal vein sampling (AVS) is being used more frequently to distinguish patients with unilateral disease for adrenalectomy, even if a discrete mass is not identified on axial imaging. In these cases, surgical pathology may reveal a cortical adenoma, a cortical adenoma with hyperplasia, or cortical hyperplasia. The goal of this study was to compare the presentation and outcome among patients undergoing adrenalectomy and found to have different histologic features.Methods
We performed a retrospective analysis of 136 patients with primary hyperaldosteronism. A total of 95 patients had an adrenalectomy for unilateral disease. The preoperative clinical and laboratory, and postoperative outcome of the three aforementioned histologic groups were compared.Results
A total of 95 patients underwent an adrenalectomy. We found no significant difference in age, gender, body mass index, duration of hypertension, number of antihypertensive medications, serum aldosterone level, serum renin level, or adrenal vein sampling ratios among the three histologic categories. We also found no significant difference among the three categories in postoperative cure rate.Conclusion
The rate of unilateral hyperplasia in patients with primary hyperaldosteronism (16 %) is likely higher than previously reported, which may be due to the increasing use of AVS. The clinical presentation and outcome of patients regardless of the histologic findings are similar. Our data also suggests that subtotal adrenalectomy would not be appropriate in patients with primary hyperaldosteronism. 相似文献9.
Sheila Mahdaviani Naris Kitnarong Justin K Kropf Peter A Netland 《Ophthalmic surgery, lasers & imaging》2006,37(5):394-398
BACKGROUND AND OBJECTIVE: To compare the efficacy of laser trabeculoplasty in pseudophakic and phakic patients with primary open-angle glaucoma (POAG). PATIENTS AND METHODS: Retrospective comparative case-control series of 42 eyes (21 pseudophakic eyes and 21 phakic eyes of patients matched for age and gender) with POAG not controlled using medical therapy and treated with laser trabeculoplasty. Success was reduction of intraocular pressure (IOP) of at least 3 mm Hg from baseline and no additional glaucoma surgery or laser treatment. uloplasty, there was no significant difference between pseudophakic and phakic eyes in the mean IOP and change from baseline IOP Success at 12 months was 78% for pseudophakic and 80% for phakic eyes. Kaplan-Meier survival analysis showed no statistically significant difference in success after laser trabeculoplasty comparing phakic to pseudophakic eyes (P = .87). CONCLUSION: In eyes with POAG, laser trabeculoplasty is as effective in pseudophakic eyes as in phakic eyes. 相似文献